BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26460229)

  • 1. Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
    Yatham LN; Beaulieu S; Schaffer A; Kauer-Sant'Anna M; Kapczinski F; Lafer B; Sharma V; Parikh SV; Daigneault A; Qian H; Bond DJ; Silverstone PH; Walji N; Milev R; Baruch P; da Cunha A; Quevedo J; Dias R; Kunz M; Young LT; Lam RW; Wong H
    Mol Psychiatry; 2016 Aug; 21(8):1050-6. PubMed ID: 26460229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone adjunctive therapy duration in the maintenance treatment of bipolar I disorder: A post hoc analysis.
    Valdes M; Bertolin S; Qian H; Wong H; Lam RW; Yatham LN
    J Affect Disord; 2019 Mar; 246():861-866. PubMed ID: 30795492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.
    Macfadden W; Alphs L; Haskins JT; Turner N; Turkoz I; Bossie C; Kujawa M; Mahmoud R
    Bipolar Disord; 2009 Dec; 11(8):827-39. PubMed ID: 19922552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
    Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium vs valproate in the maintenance treatment of bipolar I disorder: A post- hoc analysis of a randomized double-blind placebo-controlled trial.
    Kang MG; Qian H; Keramatian K; Chakrabarty T; Saraf G; Lam RW; Wong H; Yatham LN
    Aust N Z J Psychiatry; 2020 Mar; 54(3):298-307. PubMed ID: 31845587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
    Tohen M; Calabrese JR; Sachs GS; Banov MD; Detke HC; Risser R; Baker RW; Chou JC; Bowden CL
    Am J Psychiatry; 2006 Feb; 163(2):247-56. PubMed ID: 16449478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine in long-term treatment for bipolar disorder.
    Cipriani A; Rendell JM; Geddes J
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004367. PubMed ID: 19160237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality risk and mood stabilizers in bipolar disorder: a propensity-score-weighted population-based cohort study in 2002-2018.
    Chan JKN; Wong CSM; Fang CZ; Hung SC; Lo HKY; Chang WC
    Epidemiol Psychiatr Sci; 2024 May; 33():e31. PubMed ID: 38779809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
    Marcus R; Khan A; Rollin L; Morris B; Timko K; Carson W; Sanchez R
    Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spotlight on olanzapine in bipolar I disorder.
    McCormack PL; Wiseman LR
    CNS Drugs; 2005; 19(6):553-5. PubMed ID: 15963003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study.
    Tohen M; Wang WV; Leboyer M; Jen KY
    J Clin Psychiatry; 2012 Jul; 73(7):e913-7. PubMed ID: 22901362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.